Kleemann, R; Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes F J, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J (Nov. de 2000). «Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1». Nature (ENGLAND) 408 (6809): 211-6. ISSN0028-0836. PMID11089976. doi:10.1038/35041591.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Lu, Chengrong; Li Yong, Zhao Yanlin, Xing Guichin, Tang Fei, Wang Qingming, Sun Yuhui, Wei Handong, Yang Xiaoming, Wu Chutse, Chen Jianguo, Guan Kun-Liang, Zhang Chenggang, Chen Huipeng, He Fuchu (Jan. de 2002). «Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway». FASEB J. (United States) 16 (1): 90-2. PMID11709497. doi:10.1096/fj.01-0506fje.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Dechend, R; Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn F G, Scheidereit C, Leutz A (Jun. de 1999). «The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators». Oncogene (ENGLAND) 18 (22): 3316-23. ISSN0950-9232. PMID10362352. doi:10.1038/sj.onc.1202717.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Caballero, Otávia L; Resto Vicente, Patturajan Meera, Meerzaman Daoud, Guo Ming Zhou, Engles James, Yochem Robert, Ratovitski Edward, Sidransky David, Jen Jin (mayo. de 2002). «Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1)». Oncogene (England) 21 (19): 3003-10. ISSN0950-9232. PMID12082530. doi:10.1038/sj.onc.1205390.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Claret, F X; Hibi M; Dhut S; Toda T; Karin M (Oct. de 1996). «A new group of conserved coactivators that increase the specificity of AP-1 transcription factors». Nature (ENGLAND) 383 (6599): 453-7. ISSN0028-0836. PMID8837781. doi:10.1038/383453a0.
issn.org
portal.issn.org
Kleemann, R; Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes F J, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J (Nov. de 2000). «Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1». Nature (ENGLAND) 408 (6809): 211-6. ISSN0028-0836. PMID11089976. doi:10.1038/35041591.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Dechend, R; Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn F G, Scheidereit C, Leutz A (Jun. de 1999). «The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators». Oncogene (ENGLAND) 18 (22): 3316-23. ISSN0950-9232. PMID10362352. doi:10.1038/sj.onc.1202717.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Caballero, Otávia L; Resto Vicente, Patturajan Meera, Meerzaman Daoud, Guo Ming Zhou, Engles James, Yochem Robert, Ratovitski Edward, Sidransky David, Jen Jin (mayo. de 2002). «Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1)». Oncogene (England) 21 (19): 3003-10. ISSN0950-9232. PMID12082530. doi:10.1038/sj.onc.1205390.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Emberley, Ethan D; Niu Yulian, Leygue Etienne, Tomes Ladislav, Gietz R Daniel, Murphy Leigh C, Watson Peter H (Apr. de 2003). «Psoriasin interacts with Jab1 and influences breast cancer progression». Cancer Res. (United States) 63 (8): 1954-61. ISSN0008-5472. PMID12702588.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Claret, F X; Hibi M; Dhut S; Toda T; Karin M (Oct. de 1996). «A new group of conserved coactivators that increase the specificity of AP-1 transcription factors». Nature (ENGLAND) 383 (6599): 453-7. ISSN0028-0836. PMID8837781. doi:10.1038/383453a0.
Kleemann, R; Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes F J, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J (Nov. de 2000). «Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1». Nature (ENGLAND) 408 (6809): 211-6. ISSN0028-0836. PMID11089976. doi:10.1038/35041591.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Lu, Chengrong; Li Yong, Zhao Yanlin, Xing Guichin, Tang Fei, Wang Qingming, Sun Yuhui, Wei Handong, Yang Xiaoming, Wu Chutse, Chen Jianguo, Guan Kun-Liang, Zhang Chenggang, Chen Huipeng, He Fuchu (Jan. de 2002). «Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway». FASEB J. (United States) 16 (1): 90-2. PMID11709497. doi:10.1096/fj.01-0506fje.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Dechend, R; Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn F G, Scheidereit C, Leutz A (Jun. de 1999). «The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators». Oncogene (ENGLAND) 18 (22): 3316-23. ISSN0950-9232. PMID10362352. doi:10.1038/sj.onc.1202717.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Caballero, Otávia L; Resto Vicente, Patturajan Meera, Meerzaman Daoud, Guo Ming Zhou, Engles James, Yochem Robert, Ratovitski Edward, Sidransky David, Jen Jin (mayo. de 2002). «Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1)». Oncogene (England) 21 (19): 3003-10. ISSN0950-9232. PMID12082530. doi:10.1038/sj.onc.1205390.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Emberley, Ethan D; Niu Yulian, Leygue Etienne, Tomes Ladislav, Gietz R Daniel, Murphy Leigh C, Watson Peter H (Apr. de 2003). «Psoriasin interacts with Jab1 and influences breast cancer progression». Cancer Res. (United States) 63 (8): 1954-61. ISSN0008-5472. PMID12702588.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Claret, F X; Hibi M; Dhut S; Toda T; Karin M (Oct. de 1996). «A new group of conserved coactivators that increase the specificity of AP-1 transcription factors». Nature (ENGLAND) 383 (6599): 453-7. ISSN0028-0836. PMID8837781. doi:10.1038/383453a0.